Correlation Between Abcam PLC and Trevi Therapeutics
Can any of the company-specific risk be diversified away by investing in both Abcam PLC and Trevi Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Abcam PLC and Trevi Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Abcam PLC and Trevi Therapeutics, you can compare the effects of market volatilities on Abcam PLC and Trevi Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Abcam PLC with a short position of Trevi Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Abcam PLC and Trevi Therapeutics.
Diversification Opportunities for Abcam PLC and Trevi Therapeutics
-0.81 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Abcam and Trevi is -0.81. Overlapping area represents the amount of risk that can be diversified away by holding Abcam PLC and Trevi Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Trevi Therapeutics and Abcam PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Abcam PLC are associated (or correlated) with Trevi Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Trevi Therapeutics has no effect on the direction of Abcam PLC i.e., Abcam PLC and Trevi Therapeutics go up and down completely randomly.
Pair Corralation between Abcam PLC and Trevi Therapeutics
Given the investment horizon of 90 days Abcam PLC is expected to generate 0.71 times more return on investment than Trevi Therapeutics. However, Abcam PLC is 1.42 times less risky than Trevi Therapeutics. It trades about 0.1 of its potential returns per unit of risk. Trevi Therapeutics is currently generating about 0.05 per unit of risk. If you would invest 1,545 in Abcam PLC on September 13, 2024 and sell it today you would earn a total of 814.00 from holding Abcam PLC or generate 52.69% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Significant |
| Accuracy | 29.29% |
| Values | Daily Returns |
Abcam PLC vs. Trevi Therapeutics
Performance |
| Timeline |
| Abcam PLC |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Trevi Therapeutics |
Abcam PLC and Trevi Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Abcam PLC and Trevi Therapeutics
The main advantage of trading using opposite Abcam PLC and Trevi Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Abcam PLC position performs unexpectedly, Trevi Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Trevi Therapeutics will offset losses from the drop in Trevi Therapeutics' long position.| Abcam PLC vs. Anebulo Pharmaceuticals | Abcam PLC vs. Adagene | Abcam PLC vs. Acrivon Therapeutics, Common | Abcam PLC vs. AnaptysBio |
| Trevi Therapeutics vs. Cue Biopharma | Trevi Therapeutics vs. AN2 Therapeutics | Trevi Therapeutics vs. Bioatla | Trevi Therapeutics vs. Spero Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Complementary Tools
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |